Australia · Delayed Price · Currency is AUD Noronex Statistics
Total Valuation
Noronex has a market cap or net worth of AUD 8.15 million. The enterprise value is 6.51 million.
| Market Cap | 8.15M |
| Enterprise Value | 6.51M |
Important Dates
The next estimated earnings date is Tuesday, March 9, 2027.
| Earnings Date | Mar 9, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
Noronex has 740.48 million shares outstanding. The number of shares has increased by 19.29% in one year.
| Current Share Class | 740.48M |
| Shares Outstanding | 740.48M |
| Shares Change (YoY) | +19.29% |
| Shares Change (QoQ) | +15.47% |
| Owned by Insiders (%) | 17.39% |
| Owned by Institutions (%) | n/a |
| Float | 372.71M |
Valuation Ratios
The trailing PE ratio is 5.87.
| PE Ratio | 5.87 |
| Forward PE | n/a |
| PS Ratio | 2.98 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.01 |
| EV / Sales | 2.41 |
| EV / EBITDA | 2.45 |
| EV / EBIT | 6.02 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.75
| Current Ratio | 14.75 |
| Quick Ratio | 10.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 57.39% and return on invested capital (ROIC) is 35.84%.
| Return on Equity (ROE) | 57.39% |
| Return on Assets (ROA) | 26.50% |
| Return on Invested Capital (ROIC) | 35.84% |
| Return on Capital Employed (ROCE) | 38.03% |
| Weighted Average Cost of Capital (WACC) | 8.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.25% in the last 52 weeks. The beta is 0.78, so Noronex's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -31.25% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 41.20 |
| Average Volume (20 Days) | 1,063,691 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Noronex had revenue of AUD 2.86 million and earned 1.15 million in profits. Earnings per share was 0.00.
| Revenue | 2.86M |
| Gross Profit | 2.86M |
| Operating Income | 1.14M |
| Pretax Income | 1.14M |
| Net Income | 1.15M |
| EBITDA | 2.81M |
| EBIT | 1.14M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1.41 million in cash and no debt, with a net cash position of 1.41 million or 0.00 per share.
| Cash & Cash Equivalents | 1.41M |
| Total Debt | n/a |
| Net Cash | 1.41M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 3.01M |
| Book Value Per Share | 0.01 |
| Working Capital | 2.56M |
Cash Flow
| Operating Cash Flow | -5.89M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.67M |
| Net Borrowing | n/a |
| Free Cash Flow | -5.89M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 100.00%, with operating and profit margins of 40.04% and 40.10%.
| Gross Margin | 100.00% |
| Operating Margin | 40.04% |
| Pretax Margin | 40.08% |
| Profit Margin | 40.10% |
| EBITDA Margin | 98.52% |
| EBIT Margin | 40.04% |
| FCF Margin | n/a |
Dividends & Yields
Noronex does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -19.29% |
| Shareholder Yield | -19.29% |
| Earnings Yield | 17.04% |
| FCF Yield | -69.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Noronex has an Altman Z-Score of 20.33 and a Piotroski F-Score of 4.
| Altman Z-Score | 20.33 |
| Piotroski F-Score | 4 |